Compare Vanguard Information Technology Index Fund ETF (VGT) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Information Technology Index Fund ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? Vanguard Information Technology Index Fund ETF trades at $121.67 (market cap $170.20B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Vanguard Information Technology Index Fund ETF is far larger — about 94.6× Vir Biotechnology Inc. Common Stock's market cap, and Vanguard Information Technology Index Fund ETF is more actively traded (2,835,027 versus 1,782,836). Which is the better fit depends on your goals — on Pluang, investors hold Vanguard Information Technology Index Fund ETF for 130 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| VGT | VIR | |
|---|---|---|
Market Cap | $170.20B | $1.80B |
Volume | 2,835,027 | 1,782,836 |
52-Week High | $129.79 | $11.78 |
52-Week Low | $83.59 | $5.12 |
Typical Hold Time | 130 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $1.36B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Vanguard Information Technology ETF (VGT) trades at $126.48, down 0.02% on the day, with a bullish technical signal from moving averages and neutral oscillators. The ETF, focused on U.S. technology stocks, lacks key valuation ratios in the provided data but has demonstrated strong historical performance, with news highlighting past annualized returns exceeding 17% over two decades. Recent articles emphasize its low expense ratio and concentration in top tech holdings like Nvidia, Apple, and Microsoft.
The outlook for VGT remains positive given technology sector growth and AI-driven momentum, but risks include high concentration in a few stocks and sensitivity to tech sector volatility. Long-term investors may benefit from its historical outperformance, though diversification and expense ratios compared to peers like IYW or QQQ warrant consideration.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vanguard Information Technology Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index/Information Technology 25/50, an index made up of stocks of large, mid-size, and small US companies within the information technology sector, as classified under the GICS. The advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VGT →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
